Esperion Therapeutics CEO Tim Mayleben's 2018 pay jumps 94% to $9.7M
Esperion Therapeutics reports 2018 executive compensation
By ExecPay News
Published: April 18, 2019
Esperion Therapeutics reported fiscal year 2018 executive compensation information on April 18, 2019.
In 2018, four executives at Esperion Therapeutics received on average a compensation package of $5.9M, a 89% increase compared to previous year.
Average pay of disclosed executives at Esperion Therapeutics
Tim M. Mayleben, Chief Executive Officer, received $9.7M in total, which increased by 94% compared to 2017. 88% of Mayleben's compensation, or $8.6M, was in option awards. Mayleben also received $115K in bonus, $360K in non-equity incentive plan, $600K in salary, as well as $82K in other compensation.
For fiscal year 2018, the median employee pay was $601,814 at Esperion Therapeutics. Therefore, the ratio of Tim M. Mayleben's pay to the median employee pay was 16 to one.
Mark. A Glickman, Chief Commercial Officer, received a compensation package of $9M. 79% of the compensation package, or $7.1M, was in option awards.
Richard B. Bartram, Chief Financial Officer, earned $2.5M in 2018.
Narendra D. Lalwani, Ph.D., FAHA, DABT, Executive Vice President, Research and Development, received $2.3M in 2018, which increases by 88% compared to 2017.
Related executives
You may also like
Source: SEC filing on April 18, 2019.